Genome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmias.
To identify genetic factors that would be predictive of individuals who require an implantable cardioverter-defibrillator (ICD), we conducted a genome-wide association study among individuals with an ICD who experienced a life-threatening arrhythmia (LTA; cases) vs. those who did not over at least a...
Main Authors: | Sarah S Murray, Erin N Smith, Nikki Villarasa, Tara Nahey, Jeff Lande, Harold Goldberg, Marian Shaw, Lawrence Rosenthal, Brian Ramza, Jamshid Alaeddini, Xinqiang Han, Samir Damani, Orhan Soykan, Robert C Kowal, Eric J Topol, GAME Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3256134?pdf=render |
Similar Items
-
Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.
by: Parkes, et al.
Published: (2000-01-01) -
Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
by: Verena Tscholl, et al.
Published: (2021-08-01) -
Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
by: Steven H Back, et al.
Published: (2019-01-01) -
Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
by: G. Malanchini, et al.
Published: (2021-04-01) -
Implantable Cardioverter Defibrillator
by: Dicky Armen Hanafy
Published: (2013-07-01)